Peptide therapy explained. Clearly. Honestly.

Peptides are short chains of amino acids that act as signaling molecules in your body. They bind to specific receptors to trigger biological processes like tissue repair, hormone regulation, and immune response. Your body naturally produces thousands of peptides — therapeutic peptides supplement or enhance these natural processes.

Most peptides are legal to possess, but the regulatory landscape is nuanced. Some peptides (like semaglutide) are FDA-approved prescription medications. Others (like BPC-157) are classified as Category 2 bulk drug substances and cannot be legally compounded by pharmacies. The legality depends on the specific peptide, its intended use, and how it's obtained.

For FDA-approved peptides like semaglutide or tirzepatide, yes — you need a prescription from a licensed healthcare provider. For non-approved peptides, they're often available through telehealth clinics under physician authority or as research chemicals, though quality and oversight vary significantly.

Pharmaceutical-grade peptides are manufactured under strict GMP (Good Manufacturing Practice) conditions with rigorous quality control. Research-grade peptides are produced for laboratory use and may have lower purity standards, less testing, and no regulatory oversight for human use. The difference in quality can be significant.

GLP-1 receptor agonists (semaglutide, tirzepatide) have the strongest evidence base with large-scale clinical trials. Thymosin beta-4 has completed several human trials. BPC-157 has extensive animal research but very limited human data. The evidence varies dramatically between peptides.

Side effects depend on the specific peptide. GLP-1 agonists commonly cause nausea and GI discomfort. Injectable peptides carry risks of injection-site reactions. Broader risks include unknown long-term effects for many peptides, contamination from unregulated sources, and potential interactions with other medications. Medical supervision is strongly recommended.

Costs vary widely. FDA-approved GLP-1 peptides can range from $300-1,500+/month depending on insurance coverage. Compounded peptides from telehealth clinics typically run $150-500/month. Research peptides may cost less but come with significant quality and safety trade-offs. Always factor in the cost of proper medical oversight.

Look for licensed healthcare providers who conduct proper medical evaluations, use pharmaceutical-grade or USP-verified compounds, provide third-party certificates of analysis, and offer ongoing monitoring. Avoid providers who skip medical consultations, make miracle claims, or can't verify their peptide sourcing.